D.A. Davidson & CO. Purchases 623 Shares of Ventas, Inc. $VTR

D.A. Davidson & CO. increased its stake in Ventas, Inc. (NYSE:VTR) by 1.9% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 34,148 shares of the real estate investment trust’s stock after purchasing an additional 623 shares during the quarter. D.A. Davidson & CO.’s holdings in Ventas were worth $2,156,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of VTR. Nuveen LLC acquired a new stake in Ventas in the 1st quarter valued at $359,113,000. JPMorgan Chase & Co. boosted its holdings in Ventas by 9.5% during the 1st quarter. JPMorgan Chase & Co. now owns 32,347,333 shares of the real estate investment trust’s stock worth $2,224,203,000 after acquiring an additional 2,811,241 shares during the last quarter. Vanguard Group Inc. boosted its holdings in Ventas by 3.7% during the 1st quarter. Vanguard Group Inc. now owns 68,941,561 shares of the real estate investment trust’s stock worth $4,740,422,000 after acquiring an additional 2,440,551 shares during the last quarter. AQR Capital Management LLC boosted its holdings in shares of Ventas by 289.6% in the 1st quarter. AQR Capital Management LLC now owns 1,603,300 shares of the real estate investment trust’s stock worth $110,243,000 after buying an additional 1,191,773 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its holdings in shares of Ventas by 40.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 3,649,367 shares of the real estate investment trust’s stock worth $250,930,000 after buying an additional 1,056,447 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Insider Transactions at Ventas

In other news, CFO Robert F. Probst sold 29,691 shares of the business’s stock in a transaction dated Monday, August 4th. The stock was sold at an average price of $68.49, for a total transaction of $2,033,536.59. Following the completion of the transaction, the chief financial officer owned 168,364 shares of the company’s stock, valued at approximately $11,531,250.36. The trade was a 14.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Debra A. Cafaro sold 219,515 shares of the business’s stock in a transaction dated Monday, October 20th. The stock was sold at an average price of $71.32, for a total value of $15,655,809.80. Following the transaction, the chief executive officer directly owned 1,145,695 shares of the company’s stock, valued at $81,710,967.40. The trade was a 16.08% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 289,072 shares of company stock valued at $20,427,497. 1.00% of the stock is owned by corporate insiders.

Ventas Trading Up 0.6%

Shares of VTR opened at $70.38 on Monday. The business’s 50-day moving average price is $68.66 and its 200-day moving average price is $66.58. Ventas, Inc. has a twelve month low of $56.68 and a twelve month high of $72.02. The stock has a market cap of $31.99 billion, a PE ratio of 163.68, a P/E/G ratio of 2.38 and a beta of 0.89. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 1.13.

Ventas (NYSE:VTR) last announced its quarterly earnings results on Wednesday, July 30th. The real estate investment trust reported $0.87 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.02. Ventas had a return on equity of 1.75% and a net margin of 3.61%.The firm had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.37 billion. During the same period in the prior year, the business posted $0.80 earnings per share. The company’s revenue was up 18.3% on a year-over-year basis. Ventas has set its FY 2025 guidance at 3.410-3.46 EPS. On average, equities analysts forecast that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 16th. Stockholders of record on Tuesday, September 30th were issued a dividend of $0.48 per share. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $1.92 annualized dividend and a dividend yield of 2.7%. Ventas’s payout ratio is presently 446.51%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Wells Fargo & Company boosted their price objective on Ventas from $77.00 to $80.00 and gave the company an “overweight” rating in a research note on Tuesday, October 21st. Morgan Stanley boosted their price objective on Ventas from $70.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, August 15th. JPMorgan Chase & Co. boosted their price objective on Ventas from $72.00 to $76.00 and gave the company an “overweight” rating in a research note on Tuesday, August 26th. Scotiabank boosted their price objective on Ventas from $72.00 to $74.00 and gave the company a “sector perform” rating in a research note on Thursday, August 28th. Finally, Cantor Fitzgerald assumed coverage on Ventas in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $77.00 price objective on the stock. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $75.46.

Ventas Company Profile

Ventas Inc (NYSE: VTR) is a leading S&P 500 real estate investment trust focused on delivering strong, sustainable shareholder returns by enabling exceptional environments that benefit a large and growing aging population. The Company's growth is fueled by its senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments.